Spot Light Researcher - Dr. Carmen Bergom

  • Over 316,000 newly diagnosed cases of breast cancer were reported in 2019 and more than 50% of these cases will receive radiation.
  • In 2016 Dr. Bergom received a WBCS grant for $100,000 WBCS. Mapping Tumor Evolution in the Radiation Response in Breast Cancer.
  • The aim of her research was to identify changes in breast tumors that will lead to improvement in radiation responses. Her work has identified changes in tumors that can improve the responses to radiation therapy in pre-clinical models of breast cancer.
  •  Her original work can now be expanded. In 2019, Dr. Bergom received a $2.3 million, 5-year grant from NIH/NCI to study Genetic Modifiers of Radiation Therapy-Induced Cardiotoxicity.
  • The overall goal is to improve the efficacy of radiation therapy in breast cancer, while minimizing the side effects from the radiation therapy.

The WBCS Scientific Review Committee

Each year, our Scientific Review Committee evaluates proposals from researchers at the Medical College of Wisconsin (MCW) to choose the most promising studies that are aligned with the mission of WBCS. We play an active role as a partner of MCW.


  • Breast cancer is the most common cancer in the US
  • 316,700 new diagnoses of breast cancer in 2019
  • 41,760 deaths from breast cancer in 2019
  • Life time risk of breast cancer is 1 in 8
  • Life time risk of dying of breast cancer is 1 in 39
  • Median age of breast cancer diagnosis is 62
  • Mammography screening increased from 29% in 1987 to 70% in 2019  

American Cancer Society



  • Prostate cancer is the third most common cancer in the US
  • 2020 estimate for new prostate cancer diagnoses is 191,930
  • 2020 mortality is estimated at 33,330
  • It is the second leading cause of cancer death in men (Lung cancer is first)
  • Lifetime risk of prostate cancer is 1 in 9
  • Life time risk of dying from prostate cancer is 1 in 41
  • Average age of diagnosis is 66


American Cancer Society



Sign up to hear from us about specials, sales, and events.